About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
Join Now
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
By
Natalie Themm
|
Published
May 22, 2025
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
Posted in
BioUtah News
|
Tagged
pathos ai
|
Comments Off
on Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI